MORE►
George Church
Ben Lamm is co-founder of Astromech. [Photo: Astromech]
Astromech Raises $20M for Next Phase of Bringing AI to Evolutionary Biology
by Lauren Lawley Head | Aug 20, 2026
The Dallas-based Colossal Biosciences spinout, now valued at $3.8 billion, is preparing forecasting pilots in health and biosecurity as it scales the model behind its predictions.
by Quincy Preston |
Nov 4, 2025
The de-extinction startup is adding more than two decades of commercial cloning expertise to its portfolio with its first acquisition.
Days before the announcement, CEO Ben Lamm laid out his playbook at Venture Dallas 2025: run toward critics, treat promises to middle-America classrooms as seriously as commitments to investors—and spin out businesses worth more than $100 million.
MORE►
by Quincy Preston |
Jun 5, 2025
In one of his first deep interviews since Colossal's dire wolf debut made global noise, Ben Lamm joins the TechStuff podcast to talk mammoths, backlash, and why he's not here to play it safe.
MORE►
by Quincy Preston |
Apr 7, 2025
“Game of Thrones” made them famous, but the prehistoric dire wolves were real—and, according to Colossal Biosciences, have now returned after 12,500 years in what it calls the world’s first successful de-extinction. The work goes beyond headlines: It could change how we save endangered species.
Meet Romulus, Remus, and Khaleesi in a video—and hear dire wolf howls for the first time in more than 12 millennia.
MORE►
Ben Lamm at the Colossal Lab in Dallas. [Photo: Colossal Biosciences]
Dallas’ Colossal Biosciences Becomes Texas’ First Decacorn, Securing $10.2B Valuation With Series C Funding
by Quincy Preston | Jan 15, 2025
Best known for its moonshot mission to revive the woolly mammoth, Colossal Biosciences has secured $200 million in Series C funding led by TWG Global. The world's first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, Colossal Biosciences is working to restore Earth's lost biodiversity, "making science fiction into science fact."
MORE►
by Lance Murray |
Oct 1, 2024
The North Texas-based foundation aims to fight the "extinction crisis" with initiatives including Colossal Biovault—"the world's largest distributed biobanking initiative"—and an array of new efforts to both preserve and "de-extinct" wildlife.
MORE►
by Lance Murray |
Feb 2, 2024
Veteran marketing executive Emily Castel has joined Colossal Bioscience, the world’s first de-extinction company, as its first chief marketing officer, bringing her global entertainment and consumer brand experience to Colossal where she will lead global efforts to scale the company’s brand, experiences, consumer products, and emerging media properties....
MORE►
by Quincy Preston and Lance Murray |
Sep 19, 2023
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
MORE►
